investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
The Role of Cyclin E in Growth Control and Tumorogenesis
Steven I Reed
0 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Steven I Reed
Scripps Research Institute
San Diego, United States
Related projects
Chandra Bartholomeusz
Development of Targeted Therapy for ERK Pathway in Breast Cancer
Breast
Laura Alice Stransky
Elucidating the mechanism of mTORC1 activation by amino acids
Breast
Pathology
Ming Tan
Glucose Metabolism and ErbB2-Mediated Cancer Progression
Breast
Dihua Yu
Target p70S6K for Chemodietary Prevention/Early Intervention of ER- Breast Cancer
Breast
Erica K Sloan
Adrenergic Regulation of Tumor Inflammation and Metastatic Dissemination
Breast
Dario Marchetti
Heparanase Mechanisms in Brain-metastatic Breast Cancer
Breast
Zhiyuan Shen
Alternative Mechanisms to Inactivate p53 During Oncogenesis
Breast
Robert A Gatenby
Application of Evolutionary Principles to Maintain Cancer Control (PQ21)
Breast
William J Murphy
1 of 3 Interdisciplinary Collaboratory for Enhancing Translational Therapeutics Utilizing Biologically, Immunologically, and Metabollically Relevant Models of Breast Cancer
Breast